Interestingly, an in vitro and in vivo study demonstrated that the activation of PPARγ inhibits cancer cell growth in vitro by inducing apoptosis through increasing caspase 3 activity, but systemic PPARγ activation increased the growth of OE33-derived transplantable adenocarcinomas in vivo due to increased cell proliferation [132]. Here, PPARG is linked to adenocarcinoma.